BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes Dis 2020;7:370-9. [PMID: 32884991 DOI: 10.1016/j.gendis.2019.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Yu H, Gong Y, Wu P, Feng Q, Liu C. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. J Ethnopharmacol 2022;284:114801. [PMID: 34748868 DOI: 10.1016/j.jep.2021.114801] [Reference Citation Analysis]
2 Chen J, Wang S, Shen J, Hu Q, Zhang Y, Ma D, Chai K. Analysis of Gut Microbiota Composition in Lung Adenocarcinoma Patients with TCM Qi-Yin Deficiency. Am J Chin Med 2021;49:1667-82. [PMID: 34488552 DOI: 10.1142/S0192415X21500786] [Reference Citation Analysis]
3 Li Z, Yu Q, Lu X, Liu Y, Ji B. Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis. Wideochir Inne Tech Maloinwazyjne 2021;16:455-71. [PMID: 34691297 DOI: 10.5114/wiitm.2021.105377] [Reference Citation Analysis]
4 Xue C, Gu X, Li L. Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma. Cancer Cell Int 2021;21:471. [PMID: 34488768 DOI: 10.1186/s12935-021-02183-5] [Reference Citation Analysis]
5 Wu Z, Wei C, Wang L, He L. Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology. Evid Based Complement Alternat Med 2021;2021:9991533. [PMID: 34306165 DOI: 10.1155/2021/9991533] [Reference Citation Analysis]
6 Liu Z, Ma H, Lai Z. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology. BMC Complement Med Ther 2021;21:263. [PMID: 34663301 DOI: 10.1186/s12906-021-03425-9] [Reference Citation Analysis]
7 Huang C, Huang Z, Hu Y, Li Z, Wu Y, Gao J. Treatment of wastewater generated from traditional Chinese medicine processing and utilization: Recent advances and future outlook. Journal of Cleaner Production 2021;291:125927. [DOI: 10.1016/j.jclepro.2021.125927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liao X, Zhang Y, Xu B, Ali A, Liu X, Jia Q. Inositol hexaphosphate sensitizes hepatocellular carcinoma to oxaliplatin relating inhibition of CCN2-LRP6-β-catenin-ABCG1 signaling pathway. J Cancer 2021;12:6071-80. [PMID: 34539880 DOI: 10.7150/jca.62141] [Reference Citation Analysis]
9 Zhang L, Ke W, Zhao X, Lu Z. Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis. Phytother Res 2022. [PMID: 35443090 DOI: 10.1002/ptr.7467] [Reference Citation Analysis]
10 Yang X, Sun J, Wen B, Wang Y, Zhang M, Chen W, Zhao W, He C, Zhong X, Liu Y, Li T, Sun H, He S. Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5. Front Pharmacol 2021;12:771046. [PMID: 34899325 DOI: 10.3389/fphar.2021.771046] [Reference Citation Analysis]
11 Liu D, Wang Z, Zhong L, Xie C, Huang X, Zhi Y, Zhang Y, Liang J, Shi Z, Huang J, Zhang S, Zhang J, Ding F, Raza F. Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/8762717] [Reference Citation Analysis]
12 Li Y, He F, Zhang Y, Pan Z, Zhang Y. Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/3833489] [Reference Citation Analysis]
13 Kim SY, Park C, Kim MY, Ji SY, Hwangbo H, Lee H, Hong SH, Han MH, Jeong JW, Kim GY, Son CG, Cheong J, Choi YH. ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts. Int J Mol Sci 2021;22:4797. [PMID: 33946527 DOI: 10.3390/ijms22094797] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Chen Z. Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms. Cancer Cell Int 2021;21:146. [PMID: 33658028 DOI: 10.1186/s12935-021-01785-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting Drug Chemo-Resistance in Cancer Using Natural Products. Biomedicines 2021;9:1353. [PMID: 34680470 DOI: 10.3390/biomedicines9101353] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tan Y, Li L, Liu H, Yu J, Wang Q, Lin Q. Chinese Medicine Leptochloa chinensis Inhibits the Malignant Behaviors of Renal Cell Carcinoma 786-O Cells by Regulating the mTOR Pathway. Evid Based Complement Alternat Med 2021;2021:5122380. [PMID: 34675984 DOI: 10.1155/2021/5122380] [Reference Citation Analysis]
17 Wang LL, Liao C, Li XQ, Dai R, Ren QW, Shi HL, Wang XP, Feng XS, Chao X. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma. Med Sci Monit 2021;27:e927624. [PMID: 33436534 DOI: 10.12659/MSM.927624] [Reference Citation Analysis]
18 Sun R, Fang L, Lv X, Fang J, Wang Y, Chen D, Wang L, Chen J, Qi Y, Tang Z, Zhang J, Tian Y. In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor. Drug Deliv 2021;28:2071-84. [PMID: 34595970 DOI: 10.1080/10717544.2021.1983077] [Reference Citation Analysis]
19 Zhang LY, Zhang JG, Yang X, Cai MH, Zhang CW, Hu ZM. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Curr Top Med Chem 2020;20:2789-800. [PMID: 33076809 DOI: 10.2174/1568026620666201019111524] [Reference Citation Analysis]
20 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
21 Dong S, Zhuang X, Yangyang L, Yan L, Houbo D, Song W, Meng X, Tiejun L. Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27497. [PMID: 34622883 DOI: 10.1097/MD.0000000000027497] [Reference Citation Analysis]